Switching to tenofovir alafenamide for nucleos(t)ide analogue-experienced patients with chronic hepatitis B: week 144 results from a real-world, multi-centre cohort study.
Journal Information
Full Title: Aliment Pharmacol Ther
Abbreviation: Aliment Pharmacol Ther
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Gastroenterology
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Declaration of personal interests : Ogawa E has received research grants from Gilead Sciences and speaker fees from Gilead Sciences and AbbVie. Other authors declare that they have no conflicts of interest. Declaration of funding interests : This work was funded by Gilead Sciences."
"Declaration of personal interests: Ogawa E has received research grants from Gilead Sciences and speaker fees from Gilead Sciences and AbbVie. Other authors declare that they have no conflicts of interest. Declaration of funding interests: This work was funded by Gilead Sciences."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025